Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BiopharmIQ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::811036897883492352.png) BiopharmIQ by Amp [@BiopharmIQ](/creator/twitter/BiopharmIQ) on x 25.7K followers
Created: 2025-07-15 16:02:39 UTC

📣 Biotech Stock News 07/15 @ Open 🧬 📰

$KAPA XX% Positive Safety Results from Phase X Trial
$PROK X% Alignment with FDA on Approval Pathway
$LSTA X% Expands Intellectual Property Portfolio
$CTXR X% Expands Distribution Network for LYMPHIR
$CVM X% Closing of $XXX Million Offering
$SLS X% Meets Primary Endpoints in Phase X Trial
$ADAG X% Regulatory Update on Clinical Development

$ATRA X% Transfer of Investigational New Drug Application
$AEMD X% Positive Data Review for Next Trial
$AQST X% International Expansion Update for Anaphylm

$PYPD -X% Long-Acting GLP-1 Delivery Platform
$GH -X% First Patient Enrolled in Cancer Study
$ATRC -X% Completes Enrollment in Clinical Trial
$AMPH -X% Aims to Quadruple Manufacturing Capacity
$ABEO -X% Gene Therapy Available at New Center
$PSTV -X% ReSPECT-LM Trial Results for REYOBIQâ„¢
$DGX -X% Introduces Testing for Oropouche Virus
$NBIX -X% Reveals Care Gaps for Rare Condition; Analysis of CAHtalog® Registry Findings; One-Year Data from Phase X Studies
$ASND -X% Phase X Data on Hypoparathyroidism Therapy
$APLS -X% Five Abstracts Accepted for Presentation
$ABOS -X% Strategic Collaboration for Alzheimer's Therapy
$LTRN -X% AI Module for Cancer Treatment Efficacy
$SXTP -XX% Pricing of Up to $XX Million Offering; Potential Babesiosis Market Size Defined; Submit MUMS Designation Request for Tafenoquine
$INKT -XX% Publication on iNKT Cells in Therapy
$RANI -XX% Pricing of $XXX Million Offering

See image for more details. 📸

![](https://pbs.twimg.com/media/Gv6RWsjWwAAhZ2N.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945152036066222141/c:line.svg)

**Related Topics**
[$atra](/topic/$atra)
[$adag](/topic/$adag)
[$sls](/topic/$sls)
[$cvm](/topic/$cvm)
[$ctxr](/topic/$ctxr)
[$lsta](/topic/$lsta)
[$prok](/topic/$prok)
[$kapa](/topic/$kapa)

[Post Link](https://x.com/BiopharmIQ/status/1945152036066222141)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BiopharmIQ Avatar BiopharmIQ by Amp @BiopharmIQ on x 25.7K followers Created: 2025-07-15 16:02:39 UTC

📣 Biotech Stock News 07/15 @ Open 🧬 📰

$KAPA XX% Positive Safety Results from Phase X Trial $PROK X% Alignment with FDA on Approval Pathway $LSTA X% Expands Intellectual Property Portfolio $CTXR X% Expands Distribution Network for LYMPHIR $CVM X% Closing of $XXX Million Offering $SLS X% Meets Primary Endpoints in Phase X Trial $ADAG X% Regulatory Update on Clinical Development

$ATRA X% Transfer of Investigational New Drug Application $AEMD X% Positive Data Review for Next Trial $AQST X% International Expansion Update for Anaphylm

$PYPD -X% Long-Acting GLP-1 Delivery Platform $GH -X% First Patient Enrolled in Cancer Study $ATRC -X% Completes Enrollment in Clinical Trial $AMPH -X% Aims to Quadruple Manufacturing Capacity $ABEO -X% Gene Therapy Available at New Center $PSTV -X% ReSPECT-LM Trial Results for REYOBIQ™ $DGX -X% Introduces Testing for Oropouche Virus $NBIX -X% Reveals Care Gaps for Rare Condition; Analysis of CAHtalog® Registry Findings; One-Year Data from Phase X Studies $ASND -X% Phase X Data on Hypoparathyroidism Therapy $APLS -X% Five Abstracts Accepted for Presentation $ABOS -X% Strategic Collaboration for Alzheimer's Therapy $LTRN -X% AI Module for Cancer Treatment Efficacy $SXTP -XX% Pricing of Up to $XX Million Offering; Potential Babesiosis Market Size Defined; Submit MUMS Designation Request for Tafenoquine $INKT -XX% Publication on iNKT Cells in Therapy $RANI -XX% Pricing of $XXX Million Offering

See image for more details. 📸

XXXXX engagements

Engagements Line Chart

Related Topics $atra $adag $sls $cvm $ctxr $lsta $prok $kapa

Post Link

post/tweet::1945152036066222141
/post/tweet::1945152036066222141